Skip to content

Radiofrequency Microtenotomy for Treatment of Rotator Cuff Tendinopathy

Alternative Treatment of Rotator Cuff Tendinopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02275689
Enrollment
34
Registered
2014-10-27
Start date
2015-03-31
Completion date
2016-12-31
Last updated
2017-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Impingement Syndrome

Keywords

Rotator cuff, Tendinosis, Impingement, radiofrequency

Brief summary

This study compare the outcome (pain, function) after Radiofrequency microtenotomy (group I) and acromioplasty (group II) for treatment of rotator cuff tendinosis in the shoulder. The outcome of both methods will be compared to the physical therapy treatment (groupIII)

Detailed description

Rotator cuff tendinosis cause pain and disability of the shoulder. Tendinosis, sometimes complicated by partial rupture, appears to be the major lesion in chronic rotator cuff tendinopathy. Important features is a poor intrinsic ability to heal. Several patients receive treatment for shoulder tendinosis each year. Conservative treatments options include rest, stretching, strengthening, ice and/or physical therapy are used with difference results. A traditional surgical treatments (acromioplasty) have been reported with variable results.. The aim of this study is to evaluate improvement of VAS and functionality using Constant score before and after treatment of rotator cuff tendinosis using radiofrequency-plasma based microtenotomy in comparison to traditional acromioplasty and physical therapy.

Interventions

PROCEDUREArthroscopic acromioplasty

Surgical intervention With arthroscopic acromion resection

PROCEDUREMicrotenotomy

Arthroscopic radiofrequency microtenotomy of rotator cuff tendon

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Impingement pain in the shoulder at least 3 months * MRI of shoulder reveal tendinosis * Classification of Acromion morphology by RTG and or MRI * daily pain

Exclusion criteria

* inflammatory joint disease * Other comorbidity in the shoulder as instability, osteoarthritis or rotator cuff tear * serious illness

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in VAS for painevery 2 weeks. during 6 monthsThe patients will have a clinical control 6,12 weeks and 6 months postoperatively. The VAS will be registered every 2 weeks via SMS during 6 months
Change from baseline in VAS for pain,6 weeks, 6 months, and 12 months

Secondary

MeasureTime frame
Change from baseline in functionality measured by constant score6 weeks, 6 months and 12 months

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026